Imlifidase
Idefirix (imlifidase) is an enzyme pharmaceutical. Imlifidase was first approved as Idefirix on 2020-08-25. It has been approved in Europe to treat immunologic desensitization and kidney transplantation.
| Trade Name | Idefirix |
|---|---|
| Common Name | Imlifidase |
| Indication | immunologic desensitization, kidney transplantation |
| Drug Class | Enzymes |
